In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most curable stage) by measuring DNA disorder rather than looking for specific ...

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

The Alzheimer’s ‘clock’ could make it easier to treat the disease early, before memory problems appear. A simple blood test might one day serve as a molecular ‘clock’ that predicts not only whether ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

Racura Oncology scientists have developed a novel blood-based molecular test designed to assess the cardioprotective effects of its lead drug candidate RC220.

AI and metabolomics research links blood chemistry to aging, with aspartate emerging as a key biomarker of physical fitness and healthy longevity. (Nanowerk News) Could a simple blood test reveal how ...